Title : Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib.

Pub. Date : 2021 Dec 15

PMID : 34551905






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Loss of chromosome 19 (25% of cases) and PIK3CA mutations (9% of cases) were associated with shorter progression-free survival in patients receiving crizotinib. Crizotinib phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha Homo sapiens